Valuation: Crossject

Market Cap 84.06M 95.94M 78.04M 71.71M 135M 9.26B 137M 930M 364M 4.53B 360M 352M 15.65B P/E 2026 *
3.77x
P/E 2027 * 2.97x
Enterprise Value 66.16M 75.51M 61.42M 56.44M 106M 7.29B 108M 732M 286M 3.57B 283M 277M 12.32B EV / Sales 2026 *
1.09x
EV / Sales 2027 * 0.88x
Free-Float
90.34%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 2001-08-07
Director of Finance/CFO - 2026-03-24
Corporate Officer/Principal - 2024-08-19
Director TitleAgeSince
Chairman 67 2009-06-25
Director/Board Member 67 -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-17.93%-.--% - - 97.89M
-0.92%-0.92%-37.25%-64.85% 89.57M
-2.03%-3.46%+61.11%-2.03% 70.54M
Average -6.96%-0.73%+11.93%-33.44% 80.05M
Weighted average by Cap. -7.68%-0.64%+6.09%-37.17%

Financials

2026 *2027 *
Net sales 60.8M 69.39M 56.44M 51.87M 97.73M 6.7B 99.17M 672M 263M 3.28B 260M 255M 11.32B 42.3M 48.28M 39.27M 36.08M 68M 4.66B 69M 468M 183M 2.28B 181M 177M 7.87B
Net income 28.3M 32.3M 26.27M 24.14M 45.49M 3.12B 46.16M 313M 122M 1.53B 121M 119M 5.27B 7.75M 8.85M 7.19M 6.61M 12.46M 853M 12.64M 85.71M 33.55M 418M 33.2M 32.49M 1.44B
Net Debt -17.9M -20.43M -16.62M -15.27M -28.77M -1.97B -29.2M -198M -77.48M -965M -76.69M -75.04M -3.33B -47M -53.64M -43.63M -40.09M -75.55M -5.18B -76.66M -520M -203M -2.53B -201M -197M -8.75B
Logo Crossject
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
99
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-